Discussion stirs around Alcobra Ltd. (NASDAQ:ADHD) this week; here is what analysts are saying.

January 6, 2018 - By Dolores Ford

 Discussion stirs around Alcobra Ltd. (NASDAQ:ADHD) this week; here is what analysts are saying.

Alcobra Ltd. (NASDAQ:ADHD) Ratings Coverage

Among 7 analysts covering Alcobra (NASDAQ:ADHD), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Alcobra had 19 analyst reports since August 9, 2015 according to SRatingsIntel. Barclays Capital downgraded Alcobra Ltd. (NASDAQ:ADHD) on Friday, October 28 to “Underweight” rating. The firm earned “Hold” rating on Monday, August 17 by Zacks. WBB Securities upgraded Alcobra Ltd. (NASDAQ:ADHD) rating on Wednesday, November 2. WBB Securities has “Hold” rating and $1.90 target. The rating was maintained by Roth Capital on Tuesday, June 21 with “Buy”. The rating was maintained by TH Capital on Friday, August 14 with “Buy”. The stock of Alcobra Ltd. (NASDAQ:ADHD) earned “Hold” rating by WBB Securities on Sunday, August 9. The stock has “Hold” rating by Roth Capital on Friday, September 29. The stock of Alcobra Ltd. (NASDAQ:ADHD) has “Equal-Weight” rating given on Monday, August 1 by Barclays Capital. The stock of Alcobra Ltd. (NASDAQ:ADHD) has “Buy” rating given on Wednesday, May 31 by Roth Capital. As per Monday, October 9, the company rating was upgraded by WBB Securities. Below is a list of Alcobra Ltd. (NASDAQ:ADHD) latest ratings and price target changes.

09/10/2017 Broker: WBB Securities Old Rating: Hold New Rating: Speculative Buy New Target: $2 Upgrade
29/09/2017 Broker: Roth Capital Rating: Hold New Target: $1.0 Downgrade
11/08/2017 Broker: Roth Capital Rating: Buy New Target: $4.0000 Maintain

The stock increased 4.29% or $0.42 during the last trading session, reaching $10.22. About 1.11M shares traded. Alcobra Ltd. (NASDAQ:ADHD) has declined 74.73% since January 6, 2017 and is downtrending. It has underperformed by 91.43% the S&P500.

More notable recent Alcobra Ltd. (NASDAQ:ADHD) news were published by: Globenewswire.com which released: “Arcturus Therapeutics Announces Presentations at Conferences in November” on October 26, 2017, also Globenewswire.com with their article: “Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge” published on September 27, 2017, Globenewswire.com published: “Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson …” on October 19, 2017. More interesting news about Alcobra Ltd. (NASDAQ:ADHD) were released by: Reuters.com and their article: “BRIEF-Alcobr, Arcturus Therapeutics agree to merge” published on September 27, 2017 as well as Marketwatch.com‘s news article titled: “Arcturus Therapeutics Ltd.” with publication date: March 01, 2012.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.